跳至主要内容
临床试验/JPRN-UMIN000002183
JPRN-UMIN000002183已完成1 期

A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703) - A Phase I/II study of combination of TS-1, CDDP plus PTX in patients with advanced/recurrent gastric cancer (OGSG 0703)

OGSG0 个研究点目标入组 40 人开始时间: 2009年7月10日最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) with bleeding from digestive tract (2) patients who cannot take orally due to some stenosis on digestive tract (3) past history of severe allergy against some medicines (4) with high volume of ascites and/or thoratic fluid (5) with severe diseases (infection, interstitial pneumonitis, pulmonary fibrosis, cardiac failure, renal failure, liver disease, uncontrollable DM) (6) with liver cirrhosis and/or jaundice (7) with psychologic disorder which needs medicines (8) with brain disorder due to brain metastasis (9) with active second cancers. (10) women under pregnancy or women expecting future birth (11) doctors decision not to register to this trial

研究者

发起方
OGSG

相似试验